Background: This case–control study aimed to examine the association between the frequency of potentially risky beverage consumption, levels of anxiety, and the prevalence of endometrial polyps.Methods: A total of 418 participants were enrolled in the study, comprising 206 cases and 212 controls. The case group consisted of patients who visited the gynecological clinic at the Affiliated Hospital of Chengdu University of Traditional Chinese Medicine and were diagnosed with endometrial polyps (Eps) based on international diagnostic criteria. The control group consisted of women of childbearing age who visited the gynecological clinic with similar clinical symptoms but did not have EPs. Basic information, consumption of potentially risky beverages (PRB), and anxiety levels for both groups were collected through a questionnaire survey. Finally, the relationship between the frequency of PRB consumption, anxiety levels, and the prevalence of EPs was evaluated.Results: In this study, we identified a significant positive association between the consumption of PRB and the prevalence of EPs. PRB intake was categorized into three groups based on the cumulative total score: 5–8 for the Low potentially risky beverages (LPRB) intake group, 9–12 for the medium potentially risky beverages (MPRB) intake group, and 13–21 for the high potentially risky beverages (HPRB) intake group. The results revealed that PRB consumption frequency was significantly associated with EPs (OR: 2.348, 95% CI: 1.153–4.78), with higher PRB intake correlating with an increased risk of EPs (p-value: 0.014). However, no significant difference was observed between the LPRB, MPRB, HPRB intake frequency groups and the different levels of anxiety (p-value: 0.793).Conclusion: Increased consumption of PRB was clearly associated with a greater risk of EPs, and over half of the participants exhibited varying degrees of anxiety. These findings suggest that the risk of EPs can be mitigated by controlling beverage intake and highlight the need for increased attention to women’s mental health.Clinical trial registration: NCT06295510.
26 November 2025 in European Journal of Integrative Medicine
Chronic pelvic pain caused by the sequelae of inflammatory pelvic disease is a common clinical condition of pelvic pain in women. At present, the main challenges in its treatment are the limited effectiveness of pain relief and the frequent recurrence of symptoms, which significantly impact patients' quality of life and impose a considerable psychological burden on them. It is a clinically challenging disease. After summarizing years of treatment experience, the author's team discovered that acupoint catgut embedding demonstrated notable clinical efficacy in managing chronic pelvic pain stemming from pelvic inflammatory disease sequelae. Compared to existing Western medicine treatment methods, acupoint catgut embedding offers advantages such as a good analgesic effect, lower recurrence rate, economic benefits, and a relatively straightforward procedure. This article provides a comprehensive guide on embedding absorbable catgut into patients' acupoints for the treatment of chronic pelvic pain in females resulting from the sequelae of pelvic inflammatory disease.
To investigate the subjective sleep characteristics of patients with polycystic ovary syndrome (PCOS) and their association with the syndrome. A case-control study was conducted, enrolling 136 patients with PCOS and 164 non-PCOS controls recruited from the gynecology outpatient department between February and October 2025. Sleep quality was assessed using a simplified questionnaire derived from core items of the Pittsburgh Sleep Quality Index. Multivariate logistic regression analysis was performed to evaluate the association between sleep problems and PCOS, with adjustment for age, body mass index (BMI), and other potential confounders. The PCOS group exhibited significantly higher prevalences of difficulty falling asleep (51.5% vs. 32.3%), non-restorative sleep (51.5% vs. 32.9%), and self-reported poor sleep quality (66.2% vs. 53.7%) compared with the control group (all p < 0.05). The prevalence of frequent dreaming was significantly higher in the PCOS group than in the control group (39.0% vs. 28.0%, p = 0.045, chi-square test). However, in the correlation analysis, frequent dreaming was not significantly associated with PCOS status ( p > 0.05). After adjustment for potential confounders, participants with moderate and high sleep problem scores demonstrated a significantly increased risk of PCOS (moderate group: adjusted odds ratio [aOR] = 1.845, 95% CI: 1.025–3.320; high group: aOR = 2.286, 95% CI: 1.054–4.959). Subjective sleep disturbances are highly prevalent among patients with PCOS, particularly characterized by difficulty falling asleep, non-restorative sleep, and perceived poor sleep quality. The severity of these sleep disturbances is independently associated with an increased risk of PCOS. Subjective sleep assessment should be incorporated into the clinical management of PCOS.